Human Factors Questions Drive Rise In FDA Inter-Center Consults
This article was originally published in The Pink Sheet Daily
Executive Summary
Formal consultations between FDA's product centers are becoming more frequent and are often triggered by questions about human factors issues, says Office of Combination Products Director Thinh Nguyen.
You may also be interested in...
FDA To Clarify Scope Of Devices Covered By Human Factors Guidance
FDA is reviewing 600-plus comments on its draft human factors guidance and plans to "be much more specific" in the final version about the types of devices subject to the new data recommendations.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?